EUVIMEDObjevte EUVIMED
Systematische ÜbersichtMetaanalyseStudienprotokollOpen access

Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies

Ananya Sri Talanki iD, Neha Bajaj iD, Twinkle Trehan iD, Sathish Thirunavukkarasu iD

JMIR Research Protocols · 2024

DOI: 10.2196/54853 ↗

At a glance

Systematische Übersicht in JMIR Research Protocols, 2024. Written by Ananya Sri Talanki and 3 co-authors. Institution: College of Arts and Sciences, Emory University, Atlanta, GA, United States. Major MEDLINE topics: COVID-19, Systematic Reviews as Topic, Diabetes Mellitus, Meta-Analysis as Topic. Cited 1 times so far (Crossref); 39 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

COVID-19, an infectious disease pandemic, affected millions of people globally, resulting in high morbidity and mortality. Causing further concern, significant proportions of COVID-19 survivors endure the lingering health effects of SARS-CoV-2, the pathogen that causes COVID-19. One of the diseases manifesting as a postacute sequela of COVID-19 (also known as “long COVID”) is new-onset diabetes.

Objective

The aim of this study is to examine the incidence of new-onset diabetes in patients with long COVID and assess the excess risk compared with individuals who tested negative for COVID-19. The study also aims to estimate the population-attributable fraction for COVID-19 as a risk factor for new-onset diabetes in long COVID and investigate the clinical course of new-onset diabetes cases.

Methods

This is a protocol for a systematic review and meta-analysis. PubMed, MEDLINE, Embase, Scopus, and Web of Science databases will be systematically searched to identify articles published between December 2019 and July 2024. A comprehensive search strategy for each database will be developed using a combination of Medical Subject Headings terms, subject headings, and text words to identify eligible studies. Cohort studies and randomized controlled trials (only control arms) involving patients with COVID-19 of any age, with follow-up data on new-onset diabetes in long COVID, will be considered for inclusion. Controls will comprise individuals who tested negative for COVID-19, with or without other respiratory tract infections. Three independent reviewers (AST, NB, and TT) will perform article selection, data extraction, and quality assessment of the studies. A fourth reviewer (ST) will review the identified studies for final inclusion in the analysis. The random-effects DerSimonian-Laird models will be used to estimate the pooled incidence proportion (%), incidence rate of diabetes (per 1000 person-years), and risk ratio (with 95% CIs) for diabetes incidence.

Results

A total of 1972 articles were identified through the initial search conducted in August 2023. After excluding duplicates, conducting title and abstract screening, and completing full-text reviews, 41 articles were found to be eligible for inclusion. The search will be updated in July 2024. Currently, data extraction is underway, and the meta-analysis is expected to be completed in August 2024. Publication of the study findings is anticipated by the end of 2024.

Conclusions

The study findings should provide valuable insights to inform both clinical practice and public health policies regarding the effective management of new-onset diabetes in patients with long COVID. International Registered Report Identifier (IRRID) DERR1-10.2196/54853

Subjects

MeSH terms (MEDLINE)

COVID-19Systematic Reviews as TopicDiabetes MellitusMeta-Analysis as TopicHumansIncidenceCohort StudiesRisk FactorsSARS-CoV-2Pandemics

Author keywords

COVID-19SARS-CoV-2cohort studiesincidencelong COVIDmeta-analysisnew-onset diabetespostacute sequelasystematic reviewtype 1 diabetestype 2 diabetes

Authors and institutions

  • College of Arts and Sciences, Emory University, Atlanta, GA, United States.
  • Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA, United States.
  • Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA, United States.

ORCID profiles: Ananya Sri Talanki, Neha Bajaj, Twinkle Trehan, Sathish Thirunavukkarasu

Cite

APA

Talanki, A. S., Bajaj, N., Trehan, T., & Thirunavukkarasu, S. (2024). Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies. JMIR Research Protocols. https://doi.org/10.2196/54853

Vancouver

Talanki AS, Bajaj N, Trehan T, Thirunavukkarasu S. Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies. JMIR Research Protocols. 2024. doi:10.2196/54853

BibTeX
@article{Talanki2024,
  author = {Talanki, Ananya Sri and Bajaj, Neha and Trehan, Twinkle and Thirunavukkarasu, Sathish},
  title = {Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies},
  journal = {JMIR Research Protocols},
  year = {2024},
  doi = {10.2196/54853}
}
Start for free →